Peripheral arterial disease in a symptomatic diabetic population: Prospective comparison of rapid unenhanced MR angiography (MRA) with contrast-enhanced MRA

American Journal of Roentgenology

Volumn 197, Issue 6, 2011, Pages 1466-1473

  Hodnett, Philip A ^a,b   Ward, Emily V ^a,b   Davarpanah, Amir H ^b   Scanlon, Timothy G ^b   Collins, Jeremy D ^b   Glielmi, Christopher B ^c   Bi, Xiaoming ^c   Koktzoglou, Ioannis ^a   Gupta, Navyash ^a   Carr, James C ^b   Edelman, Robert R ^a  

^a NORTHSHORE UNIVERSITY HEALTHSYSTEM   (United States)

^b NORTHWESTERN MEMORIAL HOSPITAL   (United States)

^c Cardiovascular MR R and D   (United States)

Author keywords

Contrast enhanced MR angiography; Diabetes; Peripheral vascular disease; Quiescent interval single shot (QISS) MR angiography; Unenhanced MR angiography

Indexed keywords

GADOBENATE DIMEGLUMINE; GADOLINIUM PENTETATE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTRAST ENHANCED MAGNETIC RESONANCE ANGIOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIGITAL SUBTRACTION ANGIOGRAPHY; FEMALE; HUMAN; IMAGE ANALYSIS; INTERMETHOD COMPARISON; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MULTICENTER STUDY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUIESCENT INTERVAL SINGLE SHOT UNENHANCED MAGNETIC RESONANCE ANGIOGRAPHY; REVASCULARIZATION; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY;

AGED; AGED, 80 AND OVER; ANGIOGRAPHY, DIGITAL SUBTRACTION; CONTRAST MEDIA; DIABETIC ANGIOPATHIES; FEMALE; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MEGLUMINE; MIDDLE AGED; ORGANOMETALLIC COMPOUNDS; PERIPHERAL VASCULAR DISEASES; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; STATISTICS, NONPARAMETRIC;

EID: 82455194915     PISSN: 0361803X     EISSN: 15463141     Source Type: Journal    
DOI: 10.2214/AJR.10.6091     Document Type: Article

References (31)

1. Criqui MH, Denenberg JO, Langer RD, Fronek A. The epidemiology of peripheral arterial disease: importance of identifying the population at risk. Vasc Med 1997; 2:221-226 (Pubitemid 27468155)
2. Hiatt WR, Hoag S, Hamman RF. Effect of diagnostic criteria on the prevalence of peripheral arterial disease: the San Luis Valley Diabetes Study. Circulation 1995; 91:1472-1479
3. Meijer WT, Hoes AW, Rutgers D, Bots ML, Hofman A, Grobbee DE. Peripheral arterial disease in the elderly: the Rotterdam Study. Arterioscler Thromb Vasc Biol 1998; 18:185-192 (Pubitemid 28277594)
4. Hirsch AT, Haskal ZJ, Hertzer NR, et al.; American Association for Vascular Surgery; Society for Vascular Surgery; Society for Cardiovascular Angiography and Interventions; Society for Vascular Medicine and Biology; Society of Interventional Radiology; ACC/AHA Task Force on Practice Guidelines Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease; American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; Vascular Disease Foundation. ACC/ AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease) endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. J Am Coll Cardiol 2006; 47:1239-1312
5. Most RS, Sinnock P. The epidemiology of lower extremity amputations in diabetic individuals. Diabetes Care 1983; 6:87-91 (Pubitemid 13144888)
6. de Vries M, Ouwendijk R, Flobbe K, et al. Peripheral arterial disease: clinical and cost comparisons between duplex US and contrast-enhanced MR angiography - a multicenter randomized trial. Radiology 2006; 240:401-410 (Pubitemid 44098635)
7. Resnick HE, Lindsay RS, McDermott MM, et al. Relationship of high and low ankle brachial index to all-cause and cardiovascular disease mortality: the Strong Heart Study. Circulation 2004; 109:733-739 (Pubitemid 38222892)
8. Koelemay MJ, Legemate DA, van Gurp JA, de Vos H, Balm R, Jacobs MJ. Diagnosis of arterial disease of the lower extremities with duplex ultrasonography. Br J Surg 1996; 83:404-409 (Pubitemid 26083184)
9. de Vries SO, Hunink MG, Polak JF. Summary receiver operating characteristic curves as a technique for meta-analysis of the diagnostic performance of duplex ultrasonography in peripheral arterial disease. Acad Radiol 1996; 3:361-369
10. Hessel SJ, Adams DF, Abrams HL. Complications of angiography. Radiology 1981; 138:273-281 (Pubitemid 11179580)
11. Rihal CS, Textor SC, Grill DE, et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 2002; 105:2259-2264 (Pubitemid 34535335)
12. Koelemay MJ, Lijmer JG, Stoker J, Legemate DA, Bossuyt PM. Magnetic resonance angiography for the evaluation of lower extremity arterial disease: a meta-analysis. JAMA 2001; 285:1338-1345 (Pubitemid 32216150)
13. Prince MR, Zhang H, Morris M, et al. Incidence of nephrogenic systemic fibrosis at two large medical centers. Radiology 2008; 248:807-816
14. Bridges MD, St. Amant BS, McNeill RB, Cernigliaro JG, Dwyer JP, Fitzpatrick PM. High-dose gadodiamide for catheter angiography and CT in patients with varying degrees of renal insufficiency: prevalence of subsequent nephrogenic systemic fibrosis and decline in renal function. AJR 2009; 192:1538-1543
15. Guerrero A, Montes R, Muñoz-Terol J, et al. Peripheral arterial disease in patients with stages IV and V chronic renal failure. Nephrol Dial Transplant 2006; 21:3525-3531 (Pubitemid 44817104)
16. Miyazaki M, Lee VS. Nonenhanced MR angiography. Radiology 2008; 248:20-43
17. Lim RP, Hecht EM, Xu J, et al. 3D nongadolinium- enhanced ECG-gated MRA of the distal lower extremities: preliminary clinical experience. J Magn Reson Imaging 2008; 28:181-189 (Pubitemid 351956482)
18. Fan Z, Sheehan J, Bi X, Liu X, Carr J, Li D. 3D noncontrast MR angiography of the distal lower extremities using flow-sensitive dephasing (FSD)-prepared balanced SSFP. Magn Reson Med 2009;62:1523-1532
19. Edelman RR, Sheehan JJ, Dunkle E, Schindler N, Carr J, Koktzoglou I. Quiescent-interval singleshot unenhanced magnetic resonance angiography of peripheral vascular disease: technical considerations and clinical feasibility. Magn Reson Med 2010; 63:951-958
20. Korosec FR, Frayne R, Grist TM, Mistretta CA. Time-resolved contrast-enhanced 3D MR angiography. Magn Reson Med 1996; 36:345-351 (Pubitemid 26299259)
21. Bueno A, Acin F, Cañibano C, Fernandez-Casado JL, Castillo E. Diagnostic accuracy of contrastenhanced magnetic resonance angiography and duplex ultrasound in patients with peripheral vascular disease. Vasc Endovascular Surg 2010;44:576-585
22. Swan JS, Carroll TJ, Kennell TW, et al. Time-resolved three-dimensional contrast-enhanced MR angiography of the peripheral vessels. Radiology 2002; 225:43-52
23. Dorweiler B, Neufang A, Kreitner KF, Schmiedt W, Oelert H. Magnetic resonance angiography unmasks reliable target vessels for pedal bypass grafting in patients with diabetes mellitus. J Vasc Surg 2002; 35:766-772
24. Baum RA, Rutter CM, Sunshine JH, et al. Multicenter trial to evaluate vascular magnetic resonance angiography of the lower extremity: American College of Radiology Rapid Technology Assessment Group. JAMA 1995; 274:875-880
25. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977; 33:159-174 (Pubitemid 8054849)
26. Dyet JF, Nicholson AA, Ettles DF. Vascular imaging and intervention in peripheral arteries in the diabetic patient. Diabetes Metab Res Rev 2000;16(suppl 1):S16-S22
27. Kreitner KF, Kalden P, Neufang A, Duber C, Krummenauer F, Kuster E. Diabetes and peripheral arterial occlusive disease: prospective comparison of contrast-enhanced three-dimensional MR angiography with conventional digital subtraction angiography. AJR 2000; 174:171-179 (Pubitemid 30030230)
28. Ouwendijk R, Kock MC, Visser K, Pattynama PM, de Haan MW, Hunink MG. Interobserver agreement for the interpretation of contrast-enhanced 3D MR angiography and MDCT angiography in peripheral arterial disease. AJR 2005;185:1261-1267
29. Wang Y, Chen CZ, Chabra SG, et al. Bolus arterial- venous transit in the lower extremity and venous contamination in bolus chase three-dimensional magnetic resonance angiography. Invest Radiol 2002; 37:458-463 (Pubitemid 34803864)
30. Dinter DJ, Neff KW, Visciani G, et al. Peripheral bolus-chase MR angiography: analysis of risk factors for nondiagnostic image quality of the calf vessels - a combined retrospective and prospective study. AJR 2009; 193:234-240
31. Sadowski EA, Bennett LK, Chan MR, et al. Nephrogenic systemic fibrosis: risk factors and incidence estimation. Radiology 2007; 243:148-157 (Pubitemid 46579705)